Aerotel Medical System Form an Alliance with Italian Leading Telemedicine Services Provider Telbios

TelbiosTelbios, the leading telemedicine services provider in Italy, has signed an exclusivity agreement with Aerotel Medical System, world leader in manufacturing of medical devices and software platforms for telemedicine and Home Care services, for exclusive marketing and distribution of Aerotel innovative products in the Italian market.

AerotelThe agreement with Aerotel expands the range of telemedicine and home care services offered by Telbios, which includes Tele-assistance, Tele-cardiology, and Tele-radiology services. Health organizations such as hospitals, private and public healthcare institutions can now offer their patients a simple and efficient means to monitor the state of their health.

"The agreement with Aerotel is important since it gives us access to devices and technologies that are state of the art and that complete Telbios’s range of services offered," says Leopold Genovesi, CEO of Telbios.

Aerotel's devices such as EKG machines allow the patients to self measure the cardiologic parameters and send them, in short time, via telephone or GSM mobile phone handset, from any location to the call center. The transmitted information can be instantly interpreted by the team of cardiologists of San Raffaele Scientific Institute in Milan working within Telbios Telemedicine Service Center on a 24 hours call basis and immediately sent to the attending GP of the patient.

"Thanks to this technology the chronically ill patients can now avail of those technologies and are offered the possibility to be monitored without leaving the comfort of their home or while travelling and still follow a tight treatment protocol that results in the benefit of their quality of life," conclude Genovesi.

"Telemedicine is a growing market all over the globe and in Italy we can also see a very positive growth," says David Rubin, President & CEO of Aerotel Medical Systems."Having Telbios as a business partner will allow us both to develop dedicated solutions to the growing Italian market."

Monitoring the chronically ill patients can be considered as an emergency on a national level: in Italy there are over 2.5 million diabetic patients, over 4 million patients suffering for respiratory dysfunction, one million of patients suffering form chronic heart failure and the number of patients under anticoagulation treatment exceeds one million. Patients with two or more chronic diseases are the 19.4% of the population.

Telemedicine is the most suitable remote follow up method for the cited pathologies. Telemedicine reduces the unnecessary hospitalizations and reduces waiting lists for medical treatment with a significant saving factor on economical resources.

TELBIOS S.p.A.
Ufficio Stampa
Danilo Magliano
Tel .: +39 02 26433759
Mobile: +39 3357 563583
Web: www.telbios.it
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Aerotel
Hazoref st. 5, Holon 58856, Israel
Tel.: +972 3 559 3222
Fax: +972 3 559 6111
Web: www.aerotel.com
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

About Telbios
Telbios is the Italian company leader for Telemedicine services and networks in civil and military health care structures, and for Home Care assistance, proposing services and customer oriented solutions.

Telbios features his services thanks to the assistance supplied by Telemedicine Service Center (TSC) where 24 h a day technic specialist operators and specialist phisicians are on hand for customer clinic data and diagnostic images recipt, management, archiving, monitoring and reporting. CST ensures a protect data access to information about single patient and enables the web clinic data sharing, with emergency intervention activity at every time.
For more information about Telbios, please visit Telbios website at www.telbios.com

About Aerotel Medical Systems
Aerotel Medical Systems is a world leader in cost-effective, high quality, user-friendly, medical diagnostic systems and devices for the home care, eHealth and Telemedicine markets. The company provides a complete disease management package, including transtelephonic Portable devices designed for a variety of remote diagnostic, and monitoring applications; a hardware and software platform; plus phone and web-based software.

Established in 1985, Aerotel has implemented its solutions in the USA, Europe, India, China, Australia, South America and many other countries worldwide.Frost & Sullivan has recently named Aerotel as "Company of the year" for the European telemedicine market. Aerotel products are CE marked and FDA cleared for marketing in the US with the intention to be used by patients themselves. They are designed for simple use and are famous for their quality and reliability.
For more information about Aerotel, please visit Aerotel website at www.aerotel.com

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...